SNY vs UNH: fair value comparison
Sanofi and UnitedHealth Group Incorporated · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, SNY currently sits closer to the top of our discount ranking. SNY carries the stronger quality grade.
| SNY | UNH | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $44.37 | $379.09 |
| 12-month range | $41.63–$47.40 | $273.98–$415.36 |
| Sector rank | #48 of 113 Healthcare | #51 of 113 Healthcare |
| Quality grade | C | D |
| Leverage | Low | Moderate |
| Margin trend | Expanding | Expanding |
| Revenue growth | Declining | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | — |
| DCF cross-check | — | Undervalued |
| 52-week position | The lower-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: SNY fair value analysis · UNH fair value analysis